Akso Health Group Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	7.92	18.43	15.13	6.67	57.37	132.62	19.23	7.82
Short-Term Investments	1.53	0	5.49	12.63	36.55	28.7	0	0
Cash & Cash Equivalents	9.45	18.43	20.62	19.29	93.93	161.32	19.23	7.82
Cash Growth	-48.71%	-10.61%	6.85%	-79.46%	-41.78%	738.79%	145.97%	-
Receivables	7.7	20	10.4	31.85	0.42	0	4.18	11.95
Inventory	1.69	7.8	0	0	0	0	0	0
Other Current Assets	1.62	16.58	-0.89	0.88	3.33	1.8	4.14	-10.15
Total Current Assets	20.46	62.81	30.12	52.02	97.68	163.12	27.55	9.62
Property, Plant & Equipment	0	0	0.07	0.76	1.25	0.77	0.43	0.25
Long-Term Investments	0	0	0	15.67	70.6	0	0	0
Other Long-Term Assets	0	0	1.5	12.02	3.72	0	0.4	12.52
Total Long-Term Assets	0	0	1.56	28.46	75.58	0.77	0.83	12.77
Total Assets	20.46	62.81	31.69	80.48	173.26	163.89	28.38	22.39
Accounts Payable	9.69	37.2	2.97	2.09	0	0	0	0.05
Deferred Revenue	0.19	0	0	0	0.3	0	0	0
Current Debt	0	0	10	0.74	0	0	0	0
Other Current Liabilities	1.74	13.32	1.45	9.53	26.26	23.85	4.88	8.33
Total Current Liabilities	11.62	50.52	14.41	12.36	26.56	23.85	4.88	8.38
Long-Term Debt	0	0	0	20.01	20	0	0	0
Other Long-Term Liabilities	0	0	0	0	0.19	0	0	0
Total Long-Term Liabilities	0	0	0	20.01	20.19	0	0	0
Total Liabilities	11.62	50.52	14.41	32.38	46.75	23.85	4.88	8.38
Total Debt	0	0	10	20.75	20	0	0	0
Debt Growth	-	-	-51.82%	3.77%	-	-	-	-
Retained Earnings	-54.47	-53.11	-36.26	-1.43	69.77	77.24	11.76	3.19
Comprehensive Income	-3.85	-1.65	-3.1	-7.05	-1.76	4.38	-1.54	-0.46
Shareholders' Equity	8.73	12.28	17.27	48.1	126.5	140.04	23.5	14.01
Net Cash / Debt	9.45	18.43	10.62	-1.46	73.93	161.32	19.23	7.82
Net Cash / Debt Growth	-48.71%	73.59%	-	-	-54.17%	738.79%	145.97%	-
Net Cash Per Share	0.14	0.31	0.22	-0.03	1.40	3.39	0.45	0.19
Working Capital	8.84	12.29	15.71	39.66	71.12	139.28	22.68	1.24
Book Value Per Share	0.38	0.62	1.06	2.96	7.79	9.34	1.67	1.00

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).